Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
R

Rainbow Children's Medicare Ltd
NSE:RAINBOW

Watchlist Manager
Rainbow Children's Medicare Ltd
NSE:RAINBOW
Watchlist
Price: 1 483.5 INR 1.76%
Market Cap: ₹150.5B
Write Note Create Alert Ask AI

Wall St Price Targets

RAINBOW Price Targets Summary
Rainbow Children's Medicare Ltd

Wall Street analysts forecast RAINBOW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RAINBOW is 1 613.77 INR with a low forecast of 1 515 INR and a high forecast of 1 785 INR.

RAINBOW Lowest Forecast
Wall Street Target
₹1 515
2% Upside
RAINBOW Average Forecast
Wall Street Target
₹1 613.77
9% Upside
RAINBOW Highest Forecast
Wall Street Target
₹1 785
20% Upside
Lowest Forecast
Price Target
1 515 INR
2% Upside
Average Forecast
Price Target
1 613.77 INR
9% Upside
Highest Forecast
Price Target
1 785 INR
20% Upside
Rainbow Children's Medicare Ltd Competitors:
Price Targets
FCL
FINEOS Corporation Holdings PLC
82% Upside
NVT
nVent Electric PLC
26% Upside
C
CTEK
CLEANTEK Industries Inc
93% Upside
FCL
FINEOS Corporation Holdings PLC
82% Upside
NVT
nVent Electric PLC
26% Upside
C
CTEK
CLEANTEK Industries Inc
93% Upside

Revenue
Forecast

15% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 19%.

What are analyst estimates?

Gross Profit
Forecast

16% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
16% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 19%.

What are analyst estimates?

Operating Income
Forecast

21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 6 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 3 years is 16%.

What are analyst estimates?

Pre-Tax Income
Forecast

25% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
25% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 25%. The projected CAGR for the next 2 years is 22%.

What are analyst estimates?

Net Income
Forecast

31% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
31% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 6 years, the compound annual growth rate for Net Income has been 31%. The projected CAGR for the next 3 years is 15%.

What are analyst estimates?

Continue RAINBOW Research

Summary
RAINBOW intrinsic value, competitors valuation, and company profile.
DCF Valuation
RAINBOW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RAINBOW stock valuation using valuation multiples.
Wall St Estimates
RAINBOW price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RAINBOW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Rainbow Children's Medicare Ltd listings:
BSE • INR
543524
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RAINBOW's stock price target?
Price Target
1 613.77 INR

According to Wall Street analysts, the average 1-year price target for RAINBOW is 1 613.77 INR with a low forecast of 1 515 INR and a high forecast of 1 785 INR.

What is the Revenue forecast for Rainbow Children's Medicare Ltd?
Projected CAGR
19%

Over the last 6 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 19%.

What is the Gross Profit forecast for Rainbow Children's Medicare Ltd?
Projected CAGR
19%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 19%.

What is the Operating Income forecast for Rainbow Children's Medicare Ltd?
Projected CAGR
16%

Over the last 6 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 3 years is 16%.

What is the Pre-Tax Income forecast for Rainbow Children's Medicare Ltd?
Projected CAGR
22%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 25%. The projected CAGR for the next 2 years is 22%.

What is the Net Income forecast for Rainbow Children's Medicare Ltd?
Projected CAGR
15%

Over the last 6 years, the compound annual growth rate for Net Income has been 31%. The projected CAGR for the next 3 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join 350,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett